Cardiac hypertrophy diminished the effects of isoproterenol on delayed rectifier potassium current in rat heart

Journal of Physiological Sciences

Volumn 56, Issue 2, 2006, Pages 173-181

  Sakatani, Tomohiko ^a   Shirayama, Takeshi ^a   Yamamoto, Taku ^a   Mani, Hiroki ^a   Shiraishi, Hirokazu ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cardiac hypertrophy; Isoproterenol; Potassium current; Rat ventricular myocyte

Indexed keywords

DELAYED RECTIFIER POTASSIUM CHANNEL; ISOPRENALINE; PHOSPHODIESTERASE; ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL L TYPE; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM;

ABDOMINAL AORTA; ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTROPHIC CARDIOMYOPATHY; MALE; NERVE CONDUCTION; NONHUMAN; PATCH CLAMP; RAT; REPOLARIZATION; STATISTICAL SIGNIFICANCE; ADRENERGIC SYSTEM; ANIMAL; DRUG EFFECT; HEART; HEART MUSCLE CELL; INNERVATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

1-METHYL-3-ISOBUTYLXANTHINE; ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM CHANNELS, L-TYPE; DELAYED RECTIFIER POTASSIUM CHANNELS; FORSKOLIN; HEART; HYPERTROPHY, LEFT VENTRICULAR; ISOPROTERENOL; MALE; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; POTASSIUM; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS;

EID: 33750139759     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.2170/physiolsci.RP002405     Document Type: Article

References (39)

1. Kahan T, Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005;91:250-6.
2. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmia in left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol. 1987;60:560-5.
3. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 1987;317:787-92.
4. Tsuji Y, Opthof T, Yasui K, Inden Y, Takemura H, Niwa N, Lu Z, Lee JK, Honjo H, Kamiya K, Kodama I. Ionic mechanism of acquired QT prolongation and torsades de pointes in rabbits with chronic complete atrioventricular block. Circulation. 2002;106:2012-8.
5. Sanguinetti MC, Keating MT. Role of delayed rectifier potassium channels in cardiac repolarization and arrhythmia. News Physiol Sci. 1997;12:152-7.
6. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. Circulation. 1996;94:1996-2012.
7. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med. 1976;294:1165-70.
8. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation. 1990;82(supp1 I):I-103-13.
9. 2+ release cascade by β-adrenergic stimulation in rat ventricular myocytes. J Physiol. 2001;533:837-48.
10. Charpentier F, Baudet S, Le Marec H. Triggered activity as a possible mechanism for arrhythmias in ventricular hypertrophy. Pacing Clin Electrophysiol. 1991;14:1735-41.
11. Han W, Wang Z, Nattel S. Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells. Am J Physiol. 2001;280:H1075-80.
12. Ks to canine ventricular repolarization. Key role for β-adrenergic receptor stimulation. Circulation. 2003;107:2753-60.
13. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195-215.
14. Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev. 2005;85:1205-53.
15. + currents among the left ventricular free wall of rats with ascending aortic stenosis. J Physiol. 2001;530:443-55.
16. Tsuji Y, Opthof T, Kamiya K, Yasui K, Liu W, Lu Z, Kodama I. Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle. Cardiovasc Res. 2000;48:300-9.
17. + current in heart: molecular basis, functional diversity, and contribution to repolarization. Acta Pharmacol Sin. 2004;25:137-45.
18. + channels KCNQ1 and ERG1 in the rat heart. Am J Physiol. 2004;286:1300-9.
19. Ks in canine hypertrophied hearts. Cardiovasc Res. 2003;57:486-96.
20. Eckardt L, Haverkamp W, Borggrefe M, Breithardt G. Experimental models of torsade de pointes. Cardiovasc Res. 1998;39:178-93.
21. Vos MA, Verduyn SC, Gorgels AP, Lipcsei GC, Wellens HJ. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation. 1995;91:864-72.
22. Duchatelle-Gourdon I, Hartzell HC, Lagrutta AA. Modulation of the delayed rectifier potassium current in frog cardiomyocytes by β-adrenergic agonists and magnesium. J Physiol. 1989;415:251-74.
23. Iijima T, Taira N. Mechanisms of β-adrenoceptor mediated increase in delayed rectifier potassium current. Tohoku J Exp Med. 1989;159:277-81.
24. Knollmann BC, Knollmann-Ritschel BE, Weissman NJ, Jones LR, Morad M. Remodeling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J Physiol. 2000;525:483-98.
25. S proteins in rat cardiac hypertrophy. J Mol Cell Cardiol. 1995;27:2287-94.
26. Scholz PM, Upsher ME, Eliades D, Kedem J, Weiss HR. Alterations in the regional beta adrenergic system in experimental left ventricular hypertrophy. Cardiovasc Res. 1990;24:65-71.
27. 1-adrenoceptor signal transduction system in pacing-induced failure in dogs with aortic stenosis-induced left ventricular hypertrophy. Mol Cell Biochem. 2000;205:67-73.
28. Fung ML, Li HY, Wong TM. Forskolin fails to activate L-type calcium current in hypertrophied cardiomyocytes of chronically hypoxic rats. Life Sci. 2002;70:1801-9.
29. Huang MW, Leone RJ Jr, Weiss HR, Tse J, Scholz PM. Effects of β-adrenoceptor stimulation on pacing-induced failure of dog hypertrophic hearts. Clin Exp Pharmacol Physiol. 2000;27:202-7.
30. Boswell-Smith V, Spina D, Page CP. Phosphodiesterase inhibitors. Br J Pharmacol. 2006;147:S252-7.
31. Kr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes. J Physiol. 2000;522:391-402.
32. + current is inhibited by β1-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways. Cardiovasc Res. 2002;53:355-62.
33. Matsuda H, Kurata Y, Imanishi S, Sato R, Shibamoto T. Effects of Angiotensin II on sustained outward currents in rat ventricular myocytes. Pflügers Arch. 2004;448:54-62.
34. 2+ handling in perfused hypertrophic hearts from Dahl salt-sensitive rats. Hypertens Res. 2003;26:643-53.
35. Kimura S, Cameron JS, Kozlovskis PL, Bassett AL, Myerburg RJ. Delayed afterdepolarizations and triggered activity induced in feline Purkinje fibers by alpha-adrenergic stimulation in the presence of elevated calcium levels. Circulation. 1984;70:1074-82.
36. Saraiva RM, Chedid NG, Quintero H CC, Diaz G LE, Masuda MO. Impaired beta-adrenergic response and decreased L-type calcium current of hypertrophied left ventricular myocytes in postinfarction heart failure. Braz J Med Biol Res. 2003;36:635-48.
37. Gao T, Puri TS, Gerhardstein BL, Chien AJ, Green RD, Hosey MM. Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J Biol Chem. 1997;272:19401-7.
38. Lugnier C, Muller B, Le Bec A, Beaudry C, Rousseau E. Characterization of indokidan-and rolipram-sensitive cyclic nucleotide phosphodiesterase in canine and human cardiac microsomal fractions. J Pharmacol Exp Ther. 1993;265:1142-51.
39. Movsesian MA, Smith CJ, Krall J, Bristow MR, Manganiello VC. Sarcoplasmic reticulum-associated cyclic adenosine 5′-monophosphate phosphodiesterase activity in normal and failing human hearts. J Clin Invest. 1991;88:15-9.